NQO1 and neoplasm: On the basis of these findings, a substrate of NAD(P)H quinone oxidoreductase 1 has been demonstrated to inhibit thrombosis by hindering tumor‐derived tissue factor and NET formation through modulation of intracellular NAD+ levels [61].